Asunaprevir and daclatasvir in hemodialysis patients with chronic hepatitis C virus genotype 1b infection

BACKGROUND AND AIM: Patients requiring hemodialysis show high morbidity with hepatitis C virus (HCV) infection, but there are difficulties associated with interferon‐based therapies. Asunaprevir and daclatasvir could help patients with HCV genotype 1b because the drugs have a nonrenal metabolism and...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:JGH Open
Päätekijät: Otsuka, Taiga, Kawaguchi, Yasunori, Mizuta, Toshihiko, Ide, Yasushi, Koga, Futa, Kumagai, Takanori, Yoshioka, Wataru, Murayama, Kenichiro, Rikitake, Osamu, Ikeda, Yuji, Ozaki, Iwata
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Wiley Publishing Asia Pty Ltd 2017
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6207006/
https://ncbi.nlm.nih.gov/pubmed/30483552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12026
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia